Phase III Randomized Study of 5-FU, CoFactor, and Avastin vs. 5-FU, LV and Avastin for First-Line Colorectal Cancer.

NCT00337389 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1200

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Colorectal Cancer
Colon Cancer
Rectal Cancer

Interventions

DRUG: 5- Fluorouracil (5-FU)
DRUG: bevacizumab (Avastin)
DRUG: Leucovorin
DRUG: CoFactor (ANX-510)

Sponsor

Mast Therapeutics, Inc.